CRXM

 
Common Stock SEC Reporting - Delinquent
Pink No Information
Contact Info
  • 11568 Sorrento Valley Rd
  • Suite 14
  • San Diego, CA 92121

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0000772320
Fiscal Year End 12/31
OTC Marketplace Pink No Information
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: DE, USA
Year of Inc. 2003
Employees 15 a/o Dec 31, 2011
Company Officers/Contacts
Christopher Reinhard President, CEO
Tracy Kent Business Affairs, Executive Director
Mira Habel Corporate Controller
Bonnie Ortega IR
Company Directors
Christopher Reinhard Chairman
Service Providers
Accounting/Auditing Firm
Marcum LLP
750 Third Ave
11th Floor
New York, NY, 10017
United States
 
Securities Counsel
Sheppard, Mullin, Richter & Hampton LLP
12275 El Camino Real
Suite 200
San Diego, CA, 92130
United States
 
Investor Relations Firm
Mission Investor Relations
3645 Marketplace Blvd.
Suite 130-280
Atlanta, GA, 30344
United States
 
Company History
  • Formerly=Cardium Therapeutics, Inc. until 10-2014
  • Formerly=Aries Ventures, Inc. until 1-06. State of Incorporation Nevada changed to Delaware concurrent with name change
  • Note=5-00 State of Incorporation Colorado changed to Nevada concurrent with name change
  • Formerly=Casmyn Corp. until 5-00
  • Formerly=Summa Metals Corp. until 10-94
CRXM Security Details
Share Structure
Market Value1 $2,495,015 a/o Jun 26, 2017
Authorized Shares 200,000,000 a/o Sep 30, 2013
Outstanding Shares 14,273,544 a/o Mar 06, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.0001
Shareholders
Shareholders of Record 100 a/o Dec 29, 2016
Short Selling Data
Short Interest 10,043 (32.3%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security